While supporting top-line growth is important, the Compliance function also has a key role to play in driving a streamlined business. According to a KPMG survey of Chief Compliance Officers, Life Sciences is the top industry expected to make investments in improving its operations, with Ethics identified as the number one category to tackle first.

For the Compliance function the journey is evolving from emphasis on standardization, to integration of the first and second lines of defense through process convergence and real-time monitoring. This article looks at our observations in working with Life Sciences companies doing just that in the Asia-Pacific region.